Cargando…

Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers

BACKGROUND: DNA methylation can regulate the role of long noncoding RNAs (lncRNAs) in the development of lung adenocarcinoma (LUAD). The present study aimed to identify methylation-driven lncRNAs and mRNAs as biomarkers in the prognosis of LUAD using bioinformatics analysis. METHODS: Differentially...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Rui, Yang, Yi-E, Yin, Yun-Hong, Zhang, Meng-Yu, Li, Hao, Qu, Yi-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764142/ https://www.ncbi.nlm.nih.gov/pubmed/31558162 http://dx.doi.org/10.1186/s12967-019-2068-z

Ejemplares similares

A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma
por: Liu, Xiao-Xia, et al.
Publicado: (2019)

A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma
por: Shen, Nan, et al.
Publicado: (2019)

STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis
por: Zhang, Wen-Di, et al.
Publicado: (2023)

Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix
por: Li, Rui, et al.
Publicado: (2020)

Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma
por: Huo, Chen, et al.
Publicado: (2020)

Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinoma
por: Pu, Weilin, et al.
Publicado: (2016)

An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance
por: Sun, Xiwei, et al.
Publicado: (2021)

Advances in deubiquitinating enzymes in lung adenocarcinoma
por: Zhou, Xi-Jia, et al.
Publicado: (2021)

Serum microRNA expression profiling revealing potential diagnostic biomarkers for lung adenocarcinoma
por: Shan, Xia, et al.
Publicado: (2020)

Transcriptome analysis reveals gender-specific differences in overall metabolic response of male and female patients in lung adenocarcinoma
por: Li, Ya, et al.
Publicado: (2020)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
por: Sun, Hao, et al.
Publicado: (2020)

Transcriptomic analysis identifies CYP27A1 as a diagnostic marker for the prognosis and immunity in lung adenocarcinoma
por: Yin, Yi, et al.
Publicado: (2023)

Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers
por: Cheng, Jinming, et al.
Publicado: (2018)

Transcriptomic analysis reveals the potential biological mechanism of AIS and lung adenocarcinoma
por: Qin, Rong-Xing, et al.
Publicado: (2023)

Diagnostic, progressive and prognostic performance of m(6)A methylation RNA regulators in lung adenocarcinoma
por: Zhuang, Zhizhi, et al.
Publicado: (2020)

Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma
por: Yang, Lei, et al.
Publicado: (2022)

Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and In Vitro Study
por: Li, Xinyan, et al.
Publicado: (2022)

Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis
por: Zhang, Meng-Yu, et al.
Publicado: (2018)

Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018)

Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma
por: Lenka, Govinda, et al.
Publicado: (2017)

Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis
por: Xue, Wei-Xiao, et al.
Publicado: (2020)

Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma
por: Li, Jingyuan, et al.
Publicado: (2020)

Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
por: Huo, Chen, et al.
Publicado: (2021)

A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers
por: Ren, Jin, et al.
Publicado: (2021)

Development and Validation of Prognostic Model for Lung Adenocarcinoma Patients Based on m6A Methylation Related Transcriptomics
por: Li, Huijun, et al.
Publicado: (2022)

Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma
por: Wu, Qian, et al.
Publicado: (2022)

Methylation Regulation of TLR3 on Immune Parameters in Lung Adenocarcinoma
por: Li, Ang, et al.
Publicado: (2021)

Diagnostic and prognostic value of the BEX family in lung adenocarcinoma
por: Zhang, Zhong-Hao, et al.
Publicado: (2019)

XXYLT1 methylation contributes to the occurrence of lung adenocarcinoma: Methylation and lung adenocarcinoma
por: Zeng, Hui, et al.
Publicado: (2021)

Integrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome
por: DU, JIANG, et al.
Publicado: (2015)

The Diagnostic Potential of SHOX2 and RASSF1A DNA Methylation in Early Lung Adenocarcinoma
por: Gao, Hong, et al.
Publicado: (2022)

Single-cell analysis reveals exosome-associated biomarkers for prognostic prediction and immunotherapy in lung adenocarcinoma
por: Lin, Shengrong, et al.
Publicado: (2023)

Platelet Count is Associated with the Rate of Lymph Node Metastasis in Lung Adenocarcinoma
por: Qu, Cheng-hao, et al.
Publicado: (2020)

LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR
por: Wang, Lu, et al.
Publicado: (2019)

Analysis of m(6)A modulator-mediated methylation modification patterns and the tumor microenvironment in lung adenocarcinoma
por: Zeng, Qing-Cui, et al.
Publicado: (2022)

Large-scale transcriptome analysis identified RNA methylation regulators as novel prognostic signatures for lung adenocarcinoma
por: Sun, Lei, et al.
Publicado: (2020)

Overexpression of hsa_circ_0001715 is a Potential Diagnostic and Prognostic Biomarker in Lung Adenocarcinoma
por: Lu, Guo-jun, et al.
Publicado: (2020)

Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers
por: Xu, Wanxue, et al.
Publicado: (2019)

Microdissection of the Bulk Transcriptome at Single-Cell Resolution Reveals Clinical Significance and Myeloid Cells Heterogeneity in Lung Adenocarcinoma
por: Wu, Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qghkcf46af7da50eu1m93qk9ga